TuHURA Biosciences (HURA) Share-based Compensation (2012 - 2026)
TuHURA Biosciences (HURA) posted Share-based Compensation of $2.14 million for Q2 2026, up 52.3% from $1.41 million a year earlier but down 23.4% from the prior quarter.
Powered by 
Analysis
TuHURA Biosciences (HURA) Share-based Compensation (2012 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Share-based Compensation at TuHURA Biosciences was $8.53 million, up 103.5% year-over-year; for FY2025, it was $6.42 million, up 228.0% from FY2024.
- Annual Share-based Compensation shows a five-year compound annual growth rate of 67.0% (FY2020 to FY2025).
- In prior years, TuHURA Biosciences' Share-based Compensation was $1.96 million in FY2024 (+309.0%), $478,890 in FY2023, $2.25 million in FY2022 (-57.4%) and $5.28 million in FY2021 (+965.9%).
- Quarterly Share-based Compensation has run from a low of -$765,110 in Q4 2023 to a high of $2.8 million in Q1 2026 over five years.
- According to Business Quant data, Share-based Compensation for the three prior quarters was $2.8 million (Q1 2026), $2.15 million (Q4 2025) and $1.45 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 200.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 160.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 369.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 128.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 234.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 362.00 Mn |
| 10 | TuHURA Biosciences | 96.16 Mn | 82.54 Mn | - | 2.14 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.14 Mn |
| Mar 31, 2026 | 2.80 Mn |
| Dec 31, 2025 | 2.15 Mn |
| Sep 30, 2025 | 1.45 Mn |
| Jun 30, 2025 | 1.41 Mn |
| Mar 31, 2025 | 1.42 Mn |
| Sep 30, 2024 | 98,000.00 |
| Mar 31, 2024 | 334,604.00 |
| Dec 31, 2023 | -765,110.00 |
| Sep 30, 2023 | 160,000.00 |
| Mar 31, 2023 | 290,000.00 |
| Dec 31, 2022 | 794,000.00 |
| Sep 30, 2022 | 518,000.00 |
| Jun 30, 2022 | -35,000.00 |
| Mar 31, 2022 | 642,000.00 |
| Dec 31, 2021 | 830,000.00 |
| Sep 30, 2021 | 811,000.00 |
| Jun 30, 2021 | 1.03 Mn |
| Mar 31, 2021 | 1.72 Mn |
| Dec 31, 2020 | 2.13 Mn |
API Access
TuHURA Biosciences Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=HURA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "HURA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=HURA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();